The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

Carson City Health and Human Services is recognizing the National Human Immunodeficiency Virus Testing Day on June 27 as a ...

Last month, the health minister said that more than half a million previously diagnosed people with HIV have been started on treatment since the end of February. But can it really be, especially since ...

Winnie Byanyima says her organization has lost almost 50% of its funding, a gap that is undermining global efforts to combat ...

A twice-yearly injection of lenacapavir would offer near-complete protection against the virus, clinical date indicate. More pharmaceutical news is about Dupixent, GLP-1 results, and more.

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

Prevention Point Philadelphia, a nonprofit, has been on the front lines of harm reduction for more than 30 years.

University of Michigan researchers have uncovered new details of the process that HIV uses to hijack cells’ transportation ...

University of Michigan researchers have uncovered new details of the process that HIV uses to hijack cells' transportation ...

AIDS orphans and vulnerable children are without support since the U.S. cut foreign assistance. A pastor has been frantically trying to find meds for an HIV-positive orphan who can no longer get them.

A 56-year-old man attended a sexual health clinic for asymptomatic rectal Chlamydia trachomatis treatment. Patient history ...